STONY BROOK, NY / ACCESS Newswire / March 26, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader ...

FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.

A new report from UK experts says research should be prioritised, including for four of the pathogen families at high risk of ...

The list of 24 infectious diseases has been created to help scientists make new tests, vaccines and medication in preparation ...